v3.26.1
Revenues
 3 Months Ended
Mar. 31, 2026
Revenue from Contract with Customer [Abstract]  
Revenues Revenues
    
The following tables present revenue disaggregated by primary geographic market where the products are sold, by product line and timing of revenue recognition:
Three Months EndedThree Months Ended
March 31, 2026March 31, 2025
 Orthopedic SurgeryGeneral SurgeryTotalOrthopedic SurgeryGeneral SurgeryTotal
Primary Geographic Markets
United States$55,933 $117,122 $173,055 $53,016 $130,746 $183,762 
Europe, Middle East & Africa38,485 30,652 69,137 35,207 28,469 63,676 
Asia Pacific30,837 11,121 41,958 29,123 14,589 43,712 
Americas (excluding the United States)22,408 10,488 32,896 20,944 9,162 30,106 
Total sales from contracts with customers$147,663 $169,383 $317,046 $138,290 $182,966 $321,256 
Timing of Revenue Recognition
Goods transferred at a point in time$136,784 $166,490 $303,274 $127,548 $180,517 $308,065 
Services transferred over time10,879 2,893 13,772 10,742 2,449 13,191 
Total sales from contracts with customers$147,663 $169,383 $317,046 $138,290 $182,966 $321,256 

Contract liability balances related to the sale of extended warranties to customers are as follows:

March 31, 2026December 31, 2025
Contract liability$23,405 $21,967 
    
Revenue recognized during the three months ended March 31, 2026 and March 31, 2025 from amounts included in contract liabilities at the beginning of the periods were $5.3 million and $5.0 million, respectively. There were no material contract assets as of March 31, 2026 and December 31, 2025.